Dr. Reddys Laboratories Ltd.

Dr. Reddy’s Laboratories has launched generic Azacitidine for Injection in the Canadian Market. The generic Azacitidine for injection 100 mg/vial, a bioequivalent generic version of VIDAZA (azacitidine for injection), is approved by Health Canada. VIDAZA is a trademark of Celgene.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.